| Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy N Gukasyan, SM Nayak Transcultural Psychiatry 59 (5), 652-664, 2022 | 85 | 2022 |
| Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... Jama 330 (9), 843-853, 2023 | 80 | 2023 |
| Psychedelics and psychotherapy S Nayak, MW Johnson Pharmacopsychiatry 54 (04), 167-175, 2021 | 53 | 2021 |
| Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports SM Nayak, N Gukasyan, FS Barrett, E Erowid, RR Griffiths Pharmacopsychiatry 54 (05), 240-245, 2021 | 42 | 2021 |
| Psychedelics and consciousness: Distinctions, demarcations, and opportunities DB Yaden, MW Johnson, RR Griffiths, MK Doss, A Garcia-Romeu, ... International Journal of Neuropsychopharmacology 24 (8), 615-623, 2021 | 35 | 2021 |
| A single belief-changing psychedelic experience is associated with increased attribution of consciousness to living and non-living entities SM Nayak, RR Griffiths Frontiers in psychology 13, 852248, 2022 | 33 | 2022 |
| Decreases in suicidality following psychedelic therapy: A meta-analysis of individual patient data across clinical trials RJ Zeifman, D Yu, N Singhal, G Wang, SM Nayak, CR Weissman The Journal of clinical psychiatry 83 (2), 39235, 2022 | 29 | 2022 |
| Belief changes associated with psychedelic use SM Nayak, M Singh, DB Yaden, RR Griffiths Journal of Psychopharmacology 37 (1), 80-92, 2023 | 28 | 2023 |
| Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying MM Sweeney, S Nayak, ES Hurwitz, LN Mitchell, TC Swift, RR Griffiths Plos one 17 (8), e0271926, 2022 | 25 | 2022 |
| Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island ND Zaller, MA Yokell, SM Nayak, JJ Fu, AR Bazazi, JD Rich Journal of Urban Health 89, 659-670, 2012 | 16 | 2012 |
| The potential of psychedelics for end of life and palliative care DB Yaden, SM Nayak, N Gukasyan, BT Anderson, RR Griffiths Disruptive psychopharmacology, 169-184, 2021 | 15 | 2021 |
| The effects of tai chi practice on intermuscular beta coherence and the rubber hand illusion CE Kerr, U Agrawal, S Nayak Frontiers in Human Neuroscience 10, 37, 2016 | 13 | 2016 |
| Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine DS Mathai, SM Nayak, DB Yaden, A Garcia-Romeu Psychopharmacology 240 (4), 827-836, 2023 | 12 | 2023 |
| Treatment disruption and childcare responsibility as risk factors for drug and alcohol use in persons in treatment for substance use disorders during the COVID-19 crisis AS Huhn, EC Strain, J Jardot, G Turner, CL Bergeria, S Nayak, KE Dunn Journal of addiction medicine 16 (1), e8-e15, 2022 | 12 | 2022 |
| Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey SM Nayak, H Jackson, ND Sepeda, DS Mathai, S So, A Yaffe, H Zaki, ... Frontiers in Psychiatry 14, 1199642, 2023 | 11 | 2023 |
| Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use N Gukasyan, RR Griffiths, DB Yaden, DG Antoine, SM Nayak Journal of Psychopharmacology 37 (7), 707-716, 2023 | 11 | 2023 |
| Control conditions in randomized trials of psychedelics: an ACTTION systematic review SM Nayak, MK Bradley, BA Kleykamp, EC Strain, RH Dworkin, ... The Journal of clinical psychiatry 84 (3), 47000, 2023 | 11 | 2023 |
| A Bayesian reanalysis of a trial of psilocybin versus escitalopram for depression SM Nayak, BA Bari, DB Yaden, MJ Spriggs, FE Rosas, JM Peill, ... Psychedelic Medicine 1 (1), 18-26, 2023 | 7 | 2023 |
| Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder SM Nayak, AS Huhn, CL Bergeria, EC Strain, KE Dunn Drug and alcohol dependence 221, 108649, 2021 | 7 | 2021 |
| Misinterpretations and omissions: a critical response to Goodwin and colleagues’ commentary on psilocybin-assisted therapy KC O’Donnell, BT Anderson, FS Barrett, MP Bogenschutz, CS Grob, ... American Journal of Psychiatry 181 (1), 74-75, 2024 | 4 | 2024 |
